Is HTA too challenging for medical devices?
This article was originally published in Clinica
The health technology assessment approach to assessing evidence is increasingly used by decision-makers trying to manage pressures on health care budgets. It is often said that because medical devices are different from pharmaceuticals, the expectations of evidence implied by HTA for devices is unreasonable. Dr Mark Charny of UK consultancy Translucency assesses how true this is